(Q68826294)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Studies on inhibitors of rat mast cell degranulation produced by microorganisms. II. Structure elucidation of eurocidins D and E (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

Streptomyces eurocidicus

1 reference

(15Z,17Z,19Z,21Z,23Z)-25-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-13-butan-2-yl-1,3,4,9,29-pentahydroxy-7,11-dioxo-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

1 reference

(15E,17Z,19Z,21Z,23E)-25-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-13-butan-2-yl-1,3,4,9,29-pentahydroxy-7,11-dioxo-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

1 reference

(15Z,17Z,19Z,21Z,23Z)-25-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-13-butan-2-yl-1,3,9,29-tetrahydroxy-7,11-dioxo-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

1 reference

(15Z,17Z,19Z,21E,23Z)-25-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-13-butan-2-yl-1,3,9,29-tetrahydroxy-7,11-dioxo-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

1 reference

(17Z,19Z,21E)-25-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-13-butan-2-yl-1,3,9,29-tetrahydroxy-7,11-dioxo-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

1 reference

(17Z,19Z,21E)-25-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-13-butan-2-yl-1,3,4,9,29-pentahydroxy-7,11-dioxo-12,31-dioxabicyclo[25.3.1]hentriaconta-15,17,19,21,23-pentaene-28-carboxylic acid

1 reference

K Nakagomi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

S Sakai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

H Tanaka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

N Tomizuka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

Y Kawakami

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

T Nakajima

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1990

1 reference

Crossref

full work available at URL

16 September 2022

https://www.jstage.jst.go.jp/article/antibiotics1968/43/5/43_5_470/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.43.470?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

470-476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.43.470?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Macrolide antibiotic studies. XVI. The structure of nystatin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.43.470

The structure of amphotericin A. II. The complete structure of the antibiotic

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.43.470

Physico-chemical and microbiological comparison of nystatin, amphotericin A and amphotericin B, and structure of amphotericin A

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.43.470

Polyene antibiotics. VII. Carbon-13 nuclear magnetic resonance evidence for cyclic hemiketals in the polyene antibiotics amphotericin B, nystatin A1, tetrin A, tetrin B, lucensomycin, and pimaricin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.43.470

Studies on inhibitors of rat mast cell degranulation produced by microorganisms. I. Screening of microorganisms, and isolation and physico-chemical properties of eurocidins C, D and E.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.43.470

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.43.462

Identifiers

DOI

10.7164/ANTIBIOTICS.43.470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2358399%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference